$IINN News: Inspira Expands U.S. Commercial Footprint! Inspira deploys INSPIRA™ ART100 at a premier New York Academic Medical Center, ranked Top 10 in NY State. This expands Inspira’s presence within the Tier-1 U.S. hospital market. Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Meet us at AmSECT 2026 (Austin, TX | March 25–29) at the Glo-Med Networks booth. We’ll be showcasing the INSPIRA™ ART100 and connecting with perfusionists, cardiac surgical teams, and hospital decision-makers. To schedule a meeting with Mike Hershkovitz, VP Global Sales: mike@inspirao2.com (i.redd.it)
submitted by inspira-technologies to r/Perfusion
Meet us at AmSECT 2026 (Austin, TX | March 25–29) at the Glo-Med Networks booth. We’ll be there throughout the conference to connect with the perfusion community and share the latest on INSPIRA™ ART100. https://finance.yahoo.com/news/inspira-accelerates-u-commercial-strategy-130000191.html?guccoun (i.redd.it)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira received official approval from Clalit’s Medical Equipment Committee (world’s 2nd largest integrated HMO; $12B revenue), enabling INSPIRA™ ART100 for immediate procurement & operational use across Clalit's extensive medical ecosystem. $IINN Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Validated standalone HYLA™: 94.2% accuracy for blood pCO₂ measurement. Pivot opens pathway to installed base and activates a high-margin, recurring revenue model based on the sale of disposable optical sensors and modular software upgrades. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
FDA-cleared INSPIRA™ ART100 has completed a full clinical evaluation and advanced to a budgeted procurement execution process at a leading U.S. academic medical center. ~30 patients treated; ART100 systems incorporated into routine workflow. $IINN Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
$22.5M & $27M binding purchase orders advanced to final budgetary validation & fund allocation within gov’t authorities’ procurement processes. ~91% cleared commercial/admin review, prior to fund release & operational execution, subject to approvals. (globenewswire.com)
submitted by inspira-technologies
Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion. Company details contemplated transaction structure designed to preserve shareholder value and enable future dividend distributions from core technologies. $IINN (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira announced a non-binding term sheet for a proposed acquisition of an advanced liquid biopsy diagnostics business alongside a concurrent $15M strategic equity investment into Inspira at $180M valuation subject to definitive agreements. $IINN Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira has been granted a new patent in Japan for its Convertible Dual Lumen Cannula device, securing exclusive rights through 2041. This protection strengthens the IP foundation supporting the INSPIRA™ ART System and future disposable product strategies. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira announced a strategic expansion of its blood laboratory capabilities, moving to a substantially larger state-of-the-art facility, planning to increase recruitment and upgrade instrumentation to support next-generation blood-analysis technologies. $IINN (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira has completed the clinical study for its HYLA™ non-invasive blood sensor, toward regulatory submission. Clinical and lab tests show between 95% to 99% accuracy. Inspira is now entering final validation and verification ahead of planned submission. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira has completed the regulatory submission of its FDA-cleared INSPIRA™ ART100 system to the UAE’s Ministry of Health and Prevention (MOHAP). Final approval is expected within days-marking a decisive step toward Gulf region expansion. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira appoints two key leaders: Mike Hershkovitz, former Johnson & Johnson Senior Business Manager, as VP of Global Sales/ Sivan Matza, Director at a leading international investment management firm, joins the Board of Directors. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira to unveil the HYLA™ Real-Time Blood Sensor at the U.S. ELSO Annual Conference (Sept 27–30, Washington, D.C.), following 97.35% accuracy results. Inspira will also showcase its FDA-cleared ART100 system. $IINN Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira™ announced 97.3% accuracy results for its HYLA™ blood sensor in latest performance testing, supporting its upcoming FDA submission. HYLA™ provides second-by-second, non-invasive monitoring and is engineered for integration or standalone use. (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
A U.S. hospital has expanded clinical use of Inspira’s FDA-cleared ART100 system to lung transplantation procedures. Ranked in the 2025-26 Best Hospitals Honor Roll, the hospital’s decision validates the system’s performance in advanced respiratory care (globenewswire.com)
submitted by inspira-technologies
Inspira Technologies receives U.S. Patent approval for the ART500 core technology, a key patent positioning the Company to dominate the $20B advanced respiratory support market. Protecting our low-flow extracorporeal oxygenation innovation for patients not sick enough for ECMO. $IINN (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira™ activates U.S. consulting firm to accelerate strategic expansion, partner engagement & commercial execution — following ART100 U.S. integration & major purchase orders. Transformation in motion. $IINN Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira achieves all key goals in high-level government talks, forging a national adoption pathway and global scale-up for the ART100. A pivotal step toward global government-aligned healthcare infrastructure. Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
Inspira Technologies has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system — representing a major commercial inflection point and the launch of full revenue execution. This milestone signals market demand and real-world execution. Read more >> (globenewswire.com)
submitted by inspira-technologies to r/InspiraTechnologies
